FDA Inspection 1222323 — Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)
The FDA completed an inspection of Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site) on August 29, 2023 in Lianyungang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 29, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)